Related Party Transactions (Details Textual) (USD $)
|
6 Months Ended |
0 Months Ended |
3 Months Ended |
12 Months Ended |
0 Months Ended |
Jun. 30, 2014
|
Dec. 09, 2013
|
Mar. 31, 2015
|
Dec. 31, 2014
|
Feb. 11, 2015
|
Related Party Transactions (Textual) |
|
|
|
|
|
Common stock, par value |
|
|
$ 0.001us-gaap_CommonStockParOrStatedValuePerShare
|
$ 0.001us-gaap_CommonStockParOrStatedValuePerShare
|
|
Gross proceeds received in Offering |
$ 12,525,000us-gaap_ProceedsFromIssuanceInitialPublicOffering
|
|
|
|
|
Placement agent [Member] |
|
|
|
|
|
Related Party Transactions (Textual) |
|
|
|
|
|
Placement agent services fees |
|
|
|
75,000atnm_PlacementAgentServicesFees / us-gaap_SubsidiarySaleOfStockAxis = atnm_PlacementAgentMember
|
|
Description of receivables of placement agent for services |
|
Agreement entered in on December 9, 2013 had similar terms as the 2012 agreement, including a cash fee equal to 10% of the gross proceeds raised, a non-accountable expense reimbursement equal to 2% of the gross proceeds raised and warrants to purchase shares of the Company's Common Stock
|
|
|
|
Description of warrants receivables by placement |
|
Warrants to purchase shares of the Company's Common Stock in an amount equal to 10% of the shares of common stock issued or issuable
|
|
|
|
Monthly fee for financial advisory services |
|
25,000atnm_PeriodicFeeForFinancialAdvisoryServices / us-gaap_SubsidiarySaleOfStockAxis = atnm_PlacementAgentMember
|
|
|
|
Repayment of amount paid to placement agent |
|
|
25,000us-gaap_RepaymentsOfDebt / us-gaap_SubsidiarySaleOfStockAxis = atnm_PlacementAgentMember
|
25,000us-gaap_RepaymentsOfDebt / us-gaap_SubsidiarySaleOfStockAxis = atnm_PlacementAgentMember
|
|
IPO [Member] |
|
|
|
|
|
Related Party Transactions (Textual) |
|
|
|
|
|
Other expenses |
125,000us-gaap_OtherExpenses / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
|
|
|
|
Amount paid to placement agent |
|
|
|
|
1,400,000atnm_AmountPaidToPlacementAgent / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
Underwritten offering common stock, Shares |
|
|
|
|
4,444,444us-gaap_StockIssuedDuringPeriodSharesNewIssues / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
Auditor Fees |
72,000atnm_AuditorFees / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
|
|
|
|
Common stock, par value |
$ 0.001us-gaap_CommonStockParOrStatedValuePerShare / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
|
|
|
|
Underwriting discount |
|
|
|
|
20,000,000atnm_UnderwritingDiscount / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
Gross proceeds received in Offering |
11,451,250us-gaap_ProceedsFromIssuanceInitialPublicOffering / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
|
|
|
18,500,000us-gaap_ProceedsFromIssuanceInitialPublicOffering / us-gaap_StatementClassOfStockAxis = us-gaap_IPOMember
|
MSKCC [Member] |
|
|
|
|
|
Related Party Transactions (Textual) |
|
|
|
|
|
Maintenance fees |
|
|
145,000atnm_MaintenanceFeesAndResearchPayments / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = atnm_MemorialSloanKetteringCancerCenterMember
|
189,537atnm_MaintenanceFeesAndResearchPayments / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = atnm_MemorialSloanKetteringCancerCenterMember
|
|
Royalty description |
|
|
Under the agreement, the Company shall pay to MSKCC on a country-by-country basis a royalty of 2% of net sales of all licensed products until the later of: (1) 10 years from the first commercial sale, or (2) when the patents expire.
|
|
|
MSKCC [Member] | Clinical Trial Agreement [Member] |
|
|
|
|
|
Related Party Transactions (Textual) |
|
|
|
|
|
Maintenance fees |
|
|
$ 282,912atnm_MaintenanceFeesAndResearchPayments / atnm_AgreementAxis = atnm_ClinicalTrialAgreementMember / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = atnm_MemorialSloanKetteringCancerCenterMember
|
$ 189,537atnm_MaintenanceFeesAndResearchPayments / atnm_AgreementAxis = atnm_ClinicalTrialAgreementMember / us-gaap_RelatedPartyTransactionsByRelatedPartyAxis = atnm_MemorialSloanKetteringCancerCenterMember
|
|